| P50 | author | Philip Prah | Q57423329 |
| | Michael King | Q76867905 |
| | Irwin Nazareth | Q30506614 |
| | David Osborn | Q38644591 |
| | Irene Petersen | Q38802755 |
| | Kate Walters | Q43412669 |
| P2093 | author name string | Joseph Hayes | |
| P2860 | cites work | The AED (antiepileptic drug) pregnancy registry: a 6-year experience | Q80098015 |
| | Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care: cohort study in the United Kingdom THIN Primary Care Database 2000-2007. | Q50803284 |
| | Utilization of valproate: extent of inpatient use in the New York State Office of Mental Health. | Q51990255 |
| | Psychotropic drug prescription patterns among patients with bipolar I disorder. | Q52066927 |
| | Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. | Q54106227 |
| | Creating medical and drug code lists to identify cases in primary care databases | Q56946048 |
| | Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports | Q58185825 |
| | Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial | Q59210536 |
| | Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study | Q60636292 |
| | Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: a 5-year naturalistic study | Q71043862 |
| | Adjunctive use of olanzapine in mood disorders: five case reports | Q74343294 |
| | Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia | Q21260279 |
| | The course of bipolar disorder | Q22241708 |
| | Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study | Q28238082 |
| | Feasibility study and methodology to create a quality-evaluated database of primary care data | Q28298837 |
| | Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group | Q28375949 |
| | Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania | Q34552561 |
| | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial | Q34616063 |
| | Treatment research in bipolar disorder: issues and recommendations | Q34969649 |
| | The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder | Q35041599 |
| | The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better | Q35180804 |
| | Accuracy of diagnosis of psychosis on general practice computer system | Q35189120 |
| | Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study | Q35825831 |
| | Transferring the costs of expensive treatments from secondary to primary care | Q36902506 |
| | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | Q37426143 |
| | Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies | Q37670925 |
| | Rapid recurrence of mania following abrupt discontinuation of lithium | Q42202510 |
| | The fetal valproate syndrome | Q42249396 |
| | A much needed BALANCE. | Q42823639 |
| | Effective treatment of mania with olanzapine: 2 case reports | Q42940014 |
| | The Read clinical classification | Q43175398 |
| | Recent trends in the incidence of recorded depression in primary care | Q43412609 |
| | Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004. | Q43737585 |
| | Trends in the treatment of bipolar disorder by outpatient psychiatrists | Q44013090 |
| | Suicide risk in bipolar disorder during treatment with lithium and divalproex | Q44586528 |
| | Lithium in bipolar and other affective disorders: prescribing practice in the UK. | Q44973814 |
| | Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 |
| | Olanzapine compared to lithium in mania: a double-blind randomized controlled trial | Q46146139 |
| | Trends in lithium prescription in Spain from 1985 to 2003. | Q46948708 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United Kingdom | Q145 |
| | database | Q8513 |
| | bipolar disorder | Q131755 |
| P304 | page(s) | e28725 | |
| P577 | publication date | 2011-12-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. | |
| P478 | volume | 6 | |